Flexible support for companies across the healthcare ecosystem
Deerfield supports a diverse portfolio of more than two hundred private and public investments across the healthcare industry.
Our interests span therapeutics, medical devices, healthcare services, diagnostics, and digital health. We invest across the capital structure and at all stages of a company’s lifecycle, from early-stage startup to mature private or public company.
With over three decades of experience and over $15B under management*, we’re able to connect people, capital, ideas, and technology in new and unexpected ways.
*As of December 31, 2024
years investing in healthcare
assets under management
team members, including 60+ MDs, JDs, and PhDs
Solving critical problems in human health through the discovery and development of new medicines against ‘undruggable’ targets
Providing tools for independent physicians to shape healthcare for the better – for patients, communities, and themselves
Seeking to support transformational medical device innovation into commercial products and enterprises
Our investment professionals are willing and able to navigate complex situations and financing dynamics.
Many years of operational expertise make us adept at navigating the complex crosscurrents that shape the healthcare and financial industries.
We can tailor flexible, creative financing options to meet the needs of entrepreneurs and corporate partners, whether public or private.
Our Portfolio
Deerfield portfolio companies strive to advance healthcare in meaningful and innovative ways.
Deerfield Discovery and Development (3DC)
Deerfield’s internal research and development engine, 3DC, works to advance early-stage therapeutics from scientific discovery through preclinical proof of concept and into the clinic for the benefit of patients.
Strategic Partnerships
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and access to innovation.